AddressPosted Date: Mar 18 2024
Senior Finance Analyst, Corporate Development
Location: GSK House, Brentford – Tottenham Court Road
‘We’re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we’re excited for our move to the vicinity of Earnshaw Street, London WC1A (“the New HQ”) by end H1 2024.’
Job Purpose
The Global Corporate Development team, reporting to the VP & Head of Corporate Development, comprises ~10 professional staff based in London/ Philadelphia plus administrative support. The team is part of the wider Global Corporate Development group that reports to the President, Corporate Development.
The Corporate Development team manages a fast-moving portfolio of strategic projects on behalf of the SVP Global Corporate Development and members of the Global Leadership Team (GLT). These strategic projects mostly relate to acquisition or sale of companies or brands by GSK as well as R&D licensing agreements. These transactions range in value from a few £’m to in excess of £1bn. Each project is unique, but all are highly confidential as they have the potential to directly impact the share price of GSK and other companies.
As the Senior Finance Analyst, Corporate Development you will be responsible for…
Supporting Corporate Development projects (eventually with the prospect of leading smaller deals as you gain experience). This is a high-profile role, which will require close interaction with GLT members, external advisers, and other senior management.
It requires strong financial and evaluation skills together with a broad understanding of the company’s business and the industry in which it operates. Excellent interpersonal and communication skills, an innovative and “self-starter” approach, an ability to deliver high quality product to tight deadlines, excellent prioritisation skills, managing ambiguity and total flexibility of response to changing business requirements are critical to success in this role. Some transaction or equity markets exposure would be expected at Grade 6, although high-potential candidates without this experience will also be considered at an initial Grade 7.
Key Responsibilities
Accountability:
The Senior Finance Analyst will be required to act as a business partner to many and varied groups from all divisions of GSK and will liaise directly with senior representatives from these groups, working as part of a team. Corporate Development projects typically involve the valuation of a target company using a range of public sources, analysis of the financial impact of acquisition on GSK and the preparation of briefing documents for a GLT audience. The projects may require the Senior Finance Analyst to assist in financial due diligence.
Support the Directors of Corporate Development in managing their own project workload. Specifically, the Senior Finance Analyst will (often under very tight time constraints) be required to build, develop, and maintain very complex spreadsheet models and to present outputs clearly and in a highly professional format.
Other occasional duties may include for example (i) the preparation of valuations relating to impairment testing of goodwill, intangible assets and entity carrying values, (ii) benchmarking against competitors (iii) the preparation and updating of reports on the GSK target universe and competitor products (iv) making recommendations on corporate actions in relation to GSK’s equity investments and (v) maintenance and improvement of the team’s standard business combination and other financial models
Complexity:
The Corporate Development and Strategy teams work routinely with Global Leadership Team members and senior management from all parts of the business. These customers have high expectations and demand high quality output in short time frames. In order to build and maintain credibility the Senior Finance Analyst must demonstrate close attention to detail, the ability to get things right first time and excellent project management skills. In addition, the Senior Finance Analyst must respond flexibly to rapidly changing priorities and timelines and be comfortable with a high degree of organisational ambiguity.
Why You?
Basic Qualifications
Undergraduate degree OR equivalent experience
Demonstrable experience in finance and/or accounting – this could be gained in house or consultancy work
Demonstrated ability to use basic valuation techniques including discounted cash flow (NPV) analysis
Strong analytical skills and ability to gather, analyse, simplify, and summarise detailed and complex information from a range of sources.
Expert proficiency in Excel and good PowerPoint skills
Ability to build partnerships across all departments e.g., Corporate Finance, Global Manufacturing and Supply, Legal, Commercial, R&D
High level of confidentiality required
Preferred Qualifications
Qualified ACA/ CIMA accountant
Developing knowledge of and interest in the dynamics of the pharmaceutical industry and what drives valuations
Accuracy with strong attention to detail.
Ability to plan and work effectively to often short timelines and flexibility to cope with changing priorities at short notice.
Ability to understand and adapt working style to suit different situations
Ability to exercise high levels of judgment.
Knowledge of Unison/Bison at a Corporate level and corporate structure; able to extract financial data from systems
Why GSK?
GSK is a global biopharma company with a special purpose – to unite science, technology, and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive.
Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years. Our R&D focus is to deliver a new generation of vaccines and medicines using the science of the immune system, human genetics, and advanced technologies to get ahead of infectious diseases, HIV, cancer, and other immune-mediated and respiratory diseases. We do all this with a commitment to operate responsibly for all our stakeholders by prioritising Innovation, Performance and Trust.
Our bold ambitions for patients are reflected in new commitments to growth and a significant step-change in delivery over the next five years. This means more GSK vaccines and medicines, including innovative new products, will reach more people who need them than ever before.
We have long believed that building trust is key to stronger performance, helping to create value for shareholders, impact for patients and society and a reason outstanding people choose to work for and with us. That is why being a responsible business is an integral part of our strategy. Taking action on environmental, social and governance issues is a key driver in our strategy.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it is also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged, and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together
Closing Date for Applications: 05/04/2024 (COB)
Please take a copy of the Job Description, as this will not be available post closure of the advert.
When applying for this role, please use the ‘cover letter’ of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.
- LI-GSK
Why Us?
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030.
Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a workplace where everyone can feel a sense of belonging and thrive as set out in our Equal and Inclusive Treatment of Employees policy. We’re committed to being more proactive at all levels so that our workforce reflects the communities we work and hire in, and our GSK leadership reflects our GSK workforce.
As an Equal Opportunity Employer, we are open to all talent. In the US, we also adhere to Affirmative Action principles. This ensures that all qualified applicants will receive equal consideration for employment without regard to neurodiversity, race/ethnicity, colour, national origin, religion, gender, pregnancy, marital status, sexual orientation, gender identity/expression, age, disability, genetic information, military service, covered/protected veteran status or any other federal, state or local protected class*(*US only).
We believe in an agile working culture for all our roles. If flexibility is important to you, we encourage you to explore with our hiring team what the opportunities are.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on Ukdiversity.recruitment@gsk.com or 0808 234 4391.
Please note should your enquiry not relate to adjustments, we will not be able to support you through these channels. However, we have created a UK Recruitment FAQ guide. Click the link and scroll to the Careers Section where you will find answers to multiple questions we receive
As you apply, we will ask you to share some personal information which is entirely voluntary. We want to have an opportunity to consider a diverse pool of qualified candidates and this information will assist us in meeting that objective and in understanding how well we are doing against our inclusion and diversity ambitions. We would really appreciate it if you could take a few moments to complete it. Rest assured, Hiring Managers do not have access to this information and we will treat your information confidentially.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.
Please note that if you are a US Licensed Healthcare Professional or Healthcare Professional as defined by the laws of the state issuing your license, GSK may be required to capture and report expenses GSK incurs, on your behalf, in the event you are afforded an interview for employment. This capture of applicable transfers of value is necessary to ensure GSK’s compliance to all federal and state US Transparency requirements. For more information, please visit GSK’s Transparency Reporting For the Record site.
We’re moving towards a more sustainable future with our new headquarters. With better public transport links and proximity to world-class science and technology institutions, we’re excited for our move to the vicinity of Earnshaw Street, London WC1A (“the New HQ”) by end H1 2024.
